Allison DeAngelis, Adam Feuerstein, and Elaine Chen

BioTech

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story

What would a Harris or Trump presidency mean for health care policy? Why did Eli Lilly’s Mounjaro and Zepbound sales miss expectations? And does Adam

Allison DeAngelis, Adam Feuerstein, and Elaine Chen October 31, 2024

BioTech

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

Are generalist investors good or bad for biotech? How did Elaine and Adam’s trip to New York go? And how long has George Church owned

Allison DeAngelis, Adam Feuerstein, and Elaine Chen September 19, 2024

BioTech

Biotech layoffs, founder-focused VC, & a big pharma exit

Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech

Allison DeAngelis, Adam Feuerstein, and Elaine Chen July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

Biotech layoffs, founder-focused VC, & a big pharma exit

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe